Anna Dorothea Wagner (Dorothea Wagner, Anna D Wagner)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Health Insurance

Prognostic Factors

Papillary Thyroid

Top Venues

Journal of the National Cancer Institute

Patient preference and adherence

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Anne Ravix, Carole Bandiera, Evelina Cardoso, Adrian Lata-Pedreira, Haithem Chtioui, Laurent Arthur Decosterd, Anna Dorothea Wagner, Marie-Paule Schneider, Chantal Csajka, Monia Guidi
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study. Cancers 16 (12) (2024)
Anne Ravix, Carole Bandiera, Evelina Cardoso, Adrian Lata-Pedreira, Haithem Chtioui, Laurent Arthur Decosterd, Anna Dorothea Wagner, Marie-Paule Schneider, Chantal Csajka, Monia Guidi
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study. Cancers 16 (12) (2024)
Carole Bandiera, Jérôme Pasquier, Isabella Locatelli, Anne Niquille, Grégoire Wuerzner, Jennifer Dotta-Celio, Anna Hachfeld, Gilles Wandeler, Anna Dorothea Wagner, Chantal Csajka, Anne Zanchi, Matthias Cavassini, Marie-Paule Schneider
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis. Patient preference and adherence 16 (2022)
Willemieke P M Dijksterhuis, Marianne C Kalff, Anna Dorothea Wagner, Rob H A Verhoeven, Valery E P P Lemmens, Martijn G H van Oijen, Suzanne Sarah Gisbertz, Mark Ivo van Berge Henegouwen, Hanneke Wilma Marlies van Laarhoven
Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study. Journal of the National Cancer Institute 113 (11) (2022)
Carole Bandiera, Evelina Cardoso, Isabella Locatelli, Antonia Digklia, Khalil Zaman, Antonella Diciolla, Valérie Cristina, Athina Stravodimou, Aedo Lopez Veronica, Ana Dolcan, Apostolos Sarivalasis, Aikaterini Liapi, Hasna Bouchaab, Angela Orcurto, Jennifer Dotta-Celio, Solange Peters, Laurent Arthur Decosterd, Nicolas Widmer, Anna Dorothea Wagner, Chantal Csajka, Marie-Paule Schneider
Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data. JMIR research protocols 10 (6) (2021)
Anna Dorothea Wagner, Heike I Grabsch, Murielle Mauer, Sandrine Marreaud, Carmela Caballero, Peter Thuss-Patience, Lothar Mueller, Annelie Elme, Markus Hermann Moehler, Uwe Martens, Yoon-Koo Kang, Sun Young Rha, Annemieke Cats, Masanori Tokunaga, Florian Lordick
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group. BMC cancer 19 (1) (2019)